Anzeige
Mehr »
Freitag, 27.06.2025 - Börsentäglich über 12.000 News
Ein echter Gamechanger: Diese News kann den Grundstein für eine Neubewertung der Rock-Tech-Aktie legen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JQ1X | ISIN: CA0717341071 | Ticker-Symbol: BVF
Tradegate
26.06.25 | 20:35
5,494 Euro
+0,31 % +0,017
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
BAUSCH HEALTH COMPANIES INC Chart 1 Jahr
5-Tage-Chart
BAUSCH HEALTH COMPANIES INC 5-Tage-Chart
RealtimeGeldBriefZeit
5,4705,51026.06.
5,4565,50526.06.

Aktuelle News zur BAUSCH HEALTH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
18.06.Bausch Health Companies Inc. - 8-K, Current Report13
14.06.Bausch Health (BHC) Jumps 8.5% as Exec Hikes Stake; Subsidiaries Raise Over $3-Billion Fresh Funds33
13.06.Bausch Health ticks higher following large director stock purchase20
10.06.Bausch Health Companies Inc. - 8-K, Current Report16
15.05.Bausch Health Companies Inc: Bausch Health shareholders approve AGM resolutions20
14.05.Bausch Health Companies Inc: Bausch Health Announces 2025 Annual Meeting of Shareholder Results477LAVAL, QC / ACCESS Newswire / May 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the election of the 10 directors nominated at its 2025 annual meeting of shareholders ("Annual...
► Artikel lesen
14.05.Bausch Health Companies Inc. - 8-K, Current Report10
BAUSCH HEALTH Aktie jetzt für 0€ handeln
09.05.Bill Ackman Took A $4 Billion Hit But Says 'Making Progress Each Day' Was Key To Recovering From The Valeant Disaster33
06.05.Bausch Health Companies Inc: Bausch Health gets positive U.S. data on Xifaxan9
06.05.Bausch Health Companies Inc: Xifaxan Treatment Following Overt Hepatic Encephalopathy Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization197New analysis suggests efficacy of Xifaxan to mitigate OHE rehospitalizations irrespective of treatment history LAVAL, QC / ACCESS Newswire / May 6, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC)...
► Artikel lesen
05.05.Bausch Health price target cut to $8 by Raymond James10
01.05.Bausch Health Q1 Earnings and Revenues Miss Estimates, Stock Down5
30.04.Bausch Health Q1 2025 slides: revenue up 6%, EBITDA grows 14% excluding B+L15
30.04.Bausch Health Companies GAAP EPS of -$0.16 misses by $0.24, revenue of $2.26B misses by $20M7
30.04.Bausch Health Companies Inc: Bausch Health Announces First Quarter 2025 Results474First Quarter Consolidated Revenues of $2.26 billion, up 5% on a Reported basis and 6% on an Organic (non-GAAP) 1 basis over the prior year periodGAAP Net Loss Attributable to Bausch Health Companies...
► Artikel lesen
30.04.Bausch Health Companies Inc. - 8-K, Current Report3
29.04.Bausch Health Companies Inc: Bausch Health's Thermage FLX receives clearance3
29.04.Bausch Health Companies Inc.: Bausch Health Announces Health Canada Clearance of Solta Medical's Thermage FLX System652A Long-Awaited Advancement in Non-Invasive Radiofrequency Skin Tightening Is Now Approved for the Canadian Market LAVAL, QC / ACCESS Newswire / April 29, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC)...
► Artikel lesen
27.04.Notable healthcare headlines for the week: Merck, Roche and Bausch Health in focus11
25.04.Bausch Health Companies Inc: Bausch Health's Solta Medical rolls out Fraxel FTX2
Weiter >>
111 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,14